TRx Biosciences Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $956K

  • Investors
  • 1

TRx Biosciences General Information

Description

Developer of oral drug delivery technology intended to improve efficacy and safety. The company focuses on novel drug-targeting technology that uses a lymphatic system to circulate treatments and disrupt small-molecule drug delivery, enabling researchers to focus on the advancement of novel drugs in areas of unmet medical need.

Contact Information

Formerly Known As
InFirst (US Holdings) Limited
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Corporate Office
  • London Bioscience Innovation Centre
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • London Bioscience Innovation Centre
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TRx Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 12-Oct-2021 $956K Completed Startup
To view TRx Biosciences’s complete valuation and funding history, request access »

TRx Biosciences Patents

TRx Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024370798-A1 Solid dispersion compositions and uses thereof Pending 29-Oct-2023
EP-4798168-A1 Solid dispersion compositions and uses thereof Pending 29-Oct-2023
WO-2025093572-A1 Solid dispersion compositions and uses thereof Inactive 29-Oct-2023
AU-2023233811-A1 Compositions having improved bioavailability of therapeutics and uses thereof Pending 14-Mar-2022
EP-4493151-A2 Compositions having improved bioavailability of therapeutics and uses thereof Pending 14-Mar-2022 A61K9/145
To view TRx Biosciences’s complete patent history, request access »

TRx Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TRx Biosciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
To view TRx Biosciences’s complete investors history, request access »

TRx Biosciences FAQs

  • When was TRx Biosciences founded?

    TRx Biosciences was founded in 2019.

  • Where is TRx Biosciences headquartered?

    TRx Biosciences is headquartered in London, United Kingdom.

  • What is the size of TRx Biosciences?

    TRx Biosciences has 4 total employees.

  • What industry is TRx Biosciences in?

    TRx Biosciences’s primary industry is Drug Delivery.

  • Is TRx Biosciences a private or public company?

    TRx Biosciences is a Private company.

  • What is TRx Biosciences’s current revenue?

    The current revenue for TRx Biosciences is .

  • How much funding has TRx Biosciences raised over time?

    TRx Biosciences has raised $956K.

  • Who are TRx Biosciences’s investors?

    has invested in TRx Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process